The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer
Articolo
Data di Pubblicazione:
2019
Abstract:
There is no sufficient evidence to establish a standard of care for patients with brain metastases (BM) from HER2+ breast cancer (BC). The aim of this study was to assess the impact of local and systemic treatments on the outcome of patients diagnosed with BM from HER2+ BC over a period of 10 years, from 2005 to 2014.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Lapatinib; SRS; Surgery; Trastuzumab; WBRT
Elenco autori:
Gori, S.; Puglisi, F.; Moroso, S.; Fabi, A.; La Verde, N.; Frassoldati, A.; Tarenzi, E.; Garrone, O.; Vici, P.; Laudadio, L.; Cretella, E.; Turazza, M.; Foglietta, J.; Leonardi, V.; Cavanna, L.; Barni, S.; Galanti, D.; Russo, A.; Marchetti, F.; Valerio, M.; Lunardi, G.; Alongi, F.; Inno, A.
Link alla scheda completa:
Pubblicato in: